Cargando…

Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries

BACKGROUND: Viral load (VL) monitoring is an essential component of the care of HIV positive individuals. Rates of VL monitoring have been shown to vary by HIV risk factor and clinical characteristics. The objective of this study was to determine whether there are differences among regions in Canada...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raboud, Janet M, Loutfy, Mona R, Su, DeSheng, Bayoumi, Ahmed M, Klein, Marina B, Cooper, Curtis, Machouf, Nima, Rourke, Sean, Walmsley, Sharon, Rachlis, Anita, Harrigan, P Richard, Smieja, Marek, Tsoukas, Christos, Montaner, Julio SG, Hogg, Robert S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844400/ https://www.ncbi.nlm.nih.gov/pubmed/20184766 http://dx.doi.org/10.1186/1471-2334-10-40

Ejemplares similares

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
por: Antoniou, Tony, et al.
Publicado: (2017)

Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care
por: Cescon, Angela, et al.
Publicado: (2015)

Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: a cohort study
por: Gillis, Jennifer, et al.
Publicado: (2015)

A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy
por: Gillis, Jennifer, et al.
Publicado: (2016)

Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
por: Patterson, Sophie, et al.
Publicado: (2015)

Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy
por: Leung, Victor, et al.
Publicado: (2013)

Gender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study
por: Cescon, Angela, et al.
Publicado: (2013)

Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort
por: Tanner, Zachary, et al.
Publicado: (2016)

Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
por: Rana, Urvi, et al.
Publicado: (2019)

Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort study
por: McClean, Alison R., et al.
Publicado: (2022)

Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study
por: Raboud, Janet, et al.
Publicado: (2013)

The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada
por: Lima, Viviane Dias, et al.
Publicado: (2015)

Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001–2011
por: Burchell, Ann N., et al.
Publicado: (2015)

Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study
por: Loutfy, Mona R., et al.
Publicado: (2009)

Viral suppression and viral rebound among young adults living with HIV in Canada
por: Palmer, Alexis, et al.
Publicado: (2018)

Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
por: Loutfy, Mona Rafik, et al.
Publicado: (2013)

Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial
por: Siou, Kaitlin, et al.
Publicado: (2016)

Harm reduction in hospitals: is it time?
por: Rachlis, Beth S, et al.
Publicado: (2009)

Rates of inappropriate antiretroviral prescription among injection drug users
por: Wood, Evan, et al.
Publicado: (2007)

Efficacy, Safety and Pharmacokinetics of Once-Daily Saquinavir Soft-Gelatin Capsule/Ritonavir in Antiretroviral-Naive, HIV-Infected Patients
por: Julio, Montaner SG, et al.
Publicado: (2006)

Relationship between Food Insecurity and Mortality among HIV-Positive Injection Drug Users Receiving Antiretroviral Therapy in British Columbia, Canada
por: Anema, Aranka, et al.
Publicado: (2013)

Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial
por: Siou, Kaitlin, et al.
Publicado: (2017)

Gender and Ethnicity Differences in HIV-related Stigma Experienced by People Living with HIV in Ontario, Canada
por: Loutfy, Mona R., et al.
Publicado: (2012)

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
por: Zhu, Jielin, et al.
Publicado: (2019)

Lost but not forgotten: A population‐based study of mortality and care trajectories among people living with HIV who are lost to follow‐up in Ontario, Canada
por: Kendall, CE, et al.
Publicado: (2018)

Canadian consensus statement on HIV and its transmission in the context of criminal law
por: Loutfy, Mona, et al.
Publicado: (2014)

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings
por: Lima, Viviane D, et al.
Publicado: (2016)

Trends in HIV prevalence, new HIV diagnoses, and mortality among adults with HIV who entered care in Ontario, 1996/1997 to 2009/2010: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2013)

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
por: Rossi, Carmine, et al.
Publicado: (2017)

Livelihood Security and Adherence to Antiretroviral Therapy in Low and Middle Income Settings: A Systematic Review
por: Rachlis, Beth S., et al.
Publicado: (2011)

Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020
por: Anema, Aranka, et al.
Publicado: (2011)

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
por: Harris, Marianne, et al.
Publicado: (2012)

Strategies to improve adherence to antiretroviral therapy and retention in care for people living with HIV in high-income countries: a protocol for an overview of systematic reviews
por: Mbuagbaw, Lawrence, et al.
Publicado: (2018)

Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study
por: Tan, Darrell H S, et al.
Publicado: (2014)

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
por: Lima, Viviane D, et al.
Publicado: (2006)

Gender Inequities in Quality of Care among HIV-Positive Individuals Initiating Antiretroviral Treatment in British Columbia, Canada (2000–2010)
por: Carter, Allison, et al.
Publicado: (2014)

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
por: Huang, Kenneth H, et al.
Publicado: (2008)

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada
por: Patterson, S, et al.
Publicado: (2017)

Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada
por: Nosyk, Bohdan, et al.
Publicado: (2013)

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vels766bqjq4h0ih3hd193e2k5